Luye Pharma Group Ltd. (OTCMKTS:LYPHF) Sees Significant Increase in Short Interest

Luye Pharma Group Ltd. (OTCMKTS:LYPHF) was the target of a significant increase in short interest during the month of July. As of July 15th, there was short interest totalling 10,485,200 shares, an increase of 19.4% from the June 30th total of 8,783,200 shares. Based on an average trading volume of 0 shares, the short-interest ratio is currently ∞ days.

Luye Pharma Group Trading Up 5.1 %

Shares of LYPHF opened at $0.39 on Tuesday. Luye Pharma Group has a 1-year low of $0.37 and a 1-year high of $0.37. The firm has a 50-day simple moving average of $0.37 and a two-hundred day simple moving average of $0.38.

Luye Pharma Group Company Profile

Luye Pharma Group Ltd., an investment holding company, develops, produces, markets, and sells pharmaceutical products worldwide. The company offers Lipusu for ovarian and breast cancer; CMNa, a chemical sensitizer for cancer radiotherapy; Tiandida for ovarian or non-small cell lung cancer; Boyounuo, an injection for the treatment of various types of cancers and other solid tumors; and Xuezhikang, a lipid-regulating drug for the treatment of hypercholesterolaemia.